Research to explore diagnosis and treatment of rare diseases
The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.
View ArticleNew resources to support Teva Pharmaceutical Industries' Tjet injector system...
Teva Pharmaceutical Industries Ltd. announced today the availability of new resources to support the recently introduced Tjet® injector system, a needle-free device designed to deliver Teva’s...
View ArticleScientists discover simple molecular test to block GOAT enzyme
Scientists at The Scripps Research Institute have designed a new molecular test that will allow researchers to look for potential drugs targeting a human metabolic enzyme believed to stimulate the...
View ArticlePerkinElmer announces new Signature Precision Panel | Prenatal diagnostic...
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that the Company's Signature Genomics Laboratories has launched its new Signature...
View ArticleOxytocin hormone holds promise for children with Prader-Willi syndrome
Prader-Willi syndrome is a rare genetic disorder which affects one child in 25,000. Children born with this syndrome have a range of complex neurological and developmental problems which continue into...
View ArticleBrains of people with anorexia and obesity are wired differently
The brains of people with anorexia and obesity are wired differently, according to new research. Neuroscientists for the first time have found that how our brains respond to food differs across a...
View ArticlePeople with Prader-Willi Syndrome may have impaired autonomic nervous system
An Australian study reveals that people with the rare genetic disorder known as Prader-Willi Syndrome may have an impaired autonomic nervous system. This discovery opens up a new way of looking at the...
View ArticlePrader-Willi children may receive relief from sleep disorders after...
Children with Prader-Willi syndrome may receive relief from sleep disorders after undergoing an adenotonsillectomy, suggests a new study from Nationwide Children's Hospital published in the November...
View ArticleUniversity of Alberta researchers help children with Down syndrome
Researchers from the University of Alberta are helping children with Down syndrome who stutter find their voice and speak with ease.
View ArticlePrader-Willi syndrome results in dysregulation of circadian and metabolic genes
Researchers with the UC Davis MIND Institute and Agilent Laboratories have found that Prader-Willi syndrome - a genetic disorder best known for causing an insatiable appetite that can lead to morbid...
View ArticleAlize Pharma initiates AZP-531 Phase I clinical trial for treatment of type 2...
Alize Pharma, a company specialized in the development of drugs for the treatment of metabolic diseases and rare diseases, announces today the launch of the first Phase I clinical trial for AZP-531,...
View ArticleScientists report major breakthrough in understanding molecular basis for...
Scientists at the Hebrew University of Jerusalem have reported a major breakthrough in understanding the molecular basis for Prader-Willi syndrome (PWS), perhaps the most studied among the class of...
View Article‘Surprising’ effect of growth hormone on BMI in normal-weight children
Researchers have found that the body mass index standard deviation score increases in normal-weight children receiving growth hormone treatment.
View ArticleDosing commences in Essentialis’ DCCR clinical study in obese Prader-Willi...
Essentialis announced today the dosing of the first patient in clinical study PC025, which is designed to evaluate the safety and efficacy of diazoxide choline controlled release tablets (DCCR) in...
View ArticleAlizé Pharma completes two Phase I clinical trials of AZP-531 in healthy...
Alizé Pharma SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, announces today the completion of two Phase I...
View ArticleGrowth hormone boosts muscle development in Prader-Willi syndrome
Randomised trial findings show a positive effect of growth hormone therapy on muscle thickness in infants with Prader-Willi syndrome.
View ArticleStudy suggests link between neonatal ghrelin and obesity risk
Our subconscious motivation to eat is powerfully and dynamically regulated by hormone signals. The gut-derived hormone ghrelin is one such key regulator, promoting appetite through its effects on...
View ArticleAlizé Pharma announces launch of AZP-531 Phase II trial in patients with...
Alizé Pharma, a company specialized in the development of drugs for the treatment of metabolic disorders and rare diseases, today announces the launch of a Phase II clinical trial of AZP-531, its...
View ArticleRhythm, Actavis announce initiation of relamorelin Phase 2b trial for...
Rhythm, a biopharmaceutical company, and Actavis plc, a leading global pharmaceutical company, announced today the initiation of a Phase 2b clinical trial assessing the efficacy and safety of...
View ArticleJohns Hopkins researchers link sperm with specific 'epigenetic tags' to autism
In a small study, Johns Hopkins researchers found that DNA from the sperm of men whose children had early signs of autism shows distinct patterns of regulatory tags that could contribute to the...
View Article